MAP microba life sciences limited

What "strong growth" ?The testing services business is yet to...

  1. 10,123 Posts.
    lightbulb Created with Sketch. 1041
    What "strong growth" ?

    The testing services business is yet to perform. Growth is sluggish and not what was projected when it IPO'd.

    The directors then decide to acquire revenue by buying a business in the UK that doesn't make a profit and to do that they do a heavily dilutive cap raising at 23 cents which was a 30% discount to the then prevailing share price.

    Shareholders have been done over. The next quarterly is likely to show a continuation of big cash burn.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.2¢
Change
-0.004(4.17%)
Mkt cap ! $47.38M
Open High Low Value Volume
9.6¢ 9.6¢ 9.2¢ $11.09K 118.8K

Buyers (Bids)

No. Vol. Price($)
5 20774 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 114482 1
View Market Depth
Last trade - 15.11pm 29/07/2025 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.